Insider · CIK 0001583977
Cormorant Asset Management, LP
Files at: BLSM, AXNX, CNST, KZR, KNSA, PTI, APLS, CLSD. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 31, 2018 PForm 4 → | Nov 2, 4:04 pm EDT | Axonics Modulation Technologies, Inc.AXNX | 133,333 | $15.00 | $1,999,995 | 1,285,827 | +11.6% | plan? |
| Oct 31, 2018 CForm 4 → | Nov 2, 4:04 pm EDT | Axonics Modulation Technologies, Inc.AXNX | 1,152,494 | — | — | 1,152,494 | — | plan? |
| Jun 25, 2018 PForm 4 → | Jun 27, 6:20 pm EDT | Kezar Life Sciences, Inc.KZR | 250,000 | $15.00 | $3,750,000 | 1,572,909 | +18.9% | plan? |
| Jun 25, 2018 CForm 4 → | Jun 27, 6:20 pm EDT | Kezar Life Sciences, Inc.KZR | 1,322,909 | — | — | 1,322,909 | — | plan? |
| May 29, 2018 PForm 4 → | May 31, 4:13 pm EDT | Kiniksa Pharmaceuticals, Ltd.KNSA | 69,444 | $18.00 | $1,249,992 | 900,443 | +8.36% | plan? |
| May 29, 2018 CForm 4 → | May 31, 4:13 pm EDT | Kiniksa Pharmaceuticals, Ltd.KNSA | 830,999 | — | — | 830,999 | — | plan? |
| Dec 14, 2017 SForm 4 → | Dec 18, 4:03 pm EST | PROTEOSTASIS THERAPEUTICS, INC.PTI | 504,027 | $4.88 | $2,461,164 | 3,300,000 | — | plan? |
| Nov 13, 2017 PForm 4 → | Nov 14, 4:31 pm EST | Apellis Pharmaceuticals, Inc.APLS | 1,071,428 | $14.00 | $14,999,992 | 3,473,925 | +44.6% | plan? |
| Nov 13, 2017 CForm 4 → | Nov 14, 4:31 pm EST | Apellis Pharmaceuticals, Inc.APLS | 2,402,497 | — | — | 2,402,497 | — | plan? |
| Dec 12, 2016 PForm 4 → | Dec 14, 4:26 pm EST | PROTEOSTASIS THERAPEUTICS, INC.PTI | 121,301 | $10.82 | $1,312,905 | 3,804,027 | +3.29% | plan? |
| Dec 7, 2016 PForm 4 → | Dec 9, 4:51 pm EST | PROTEOSTASIS THERAPEUTICS, INC.PTI | 44,417 | $10.83 | $481,189 | 3,682,726 | +1.22% | plan? |
| Dec 2, 2016 PForm 4 → | Dec 6, 5:01 pm EST | PROTEOSTASIS THERAPEUTICS, INC.PTI | 87,973 | $10.62 | $934,123 | 3,638,309 | +2.48% | plan? |
| Nov 29, 2016 PForm 4 → | Dec 1, 4:59 pm EST | PROTEOSTASIS THERAPEUTICS, INC.PTI | 170,391 | $10.24 | $1,744,116 | 3,550,336 | +5.04% | plan? |
| Nov 21, 2016 PForm 4 → | Nov 23, 5:24 pm EST | PROTEOSTASIS THERAPEUTICS, INC.PTI | 361,863 | $11.40 | $4,124,945 | 3,379,945 | +12.0% | plan? |
| Nov 9, 2016 PForm 4 → | Nov 14, 5:33 pm EST | PROTEOSTASIS THERAPEUTICS, INC.PTI | 259,500 | $11.05 | $2,867,700 | 3,018,082 | +9.41% | plan? late |
| Nov 3, 2016 PForm 4 → | Nov 7, 6:11 pm EST | PROTEOSTASIS THERAPEUTICS, INC.PTI | 327,977 | $8.45 | $2,772,280 | 2,758,582 | +13.5% | plan? |
Reported trades — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 31, 2018 CForm 4 → | Nov 2, 4:04 pm EDT | Axonics Modulation Technologies, Inc.AXNX | 1,152,494 | — | — | 0 | — | |
| Jun 25, 2018 CForm 4 → | Jun 27, 6:20 pm EDT | Kezar Life Sciences, Inc.KZR | 1,322,909 | — | — | 0 | — | |
| May 29, 2018 CForm 4 → | May 31, 4:13 pm EDT | Kiniksa Pharmaceuticals, Ltd.KNSA | 830,999 | — | — | 0 | — | |
| Nov 13, 2017 CForm 4 → | Nov 14, 4:31 pm EST | Apellis Pharmaceuticals, Inc.APLS | 2,402,497 | — | — | 0 | — |